Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 7
2003 13
2004 6
2005 9
2006 7
2007 6
2008 10
2009 21
2010 22
2011 31
2012 37
2013 38
2014 34
2015 42
2016 41
2017 47
2018 37
2019 38
2020 85
2021 111
2022 131
2023 149
2024 154
2025 168
2026 113

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,200 results

Results by year

Filters applied: . Clear all
Page 1
Nivolumab+AVD in Advanced-Stage Classic Hodgkin's Lymphoma.
Herrera AF, LeBlanc M, Castellino SM, Li H, Rutherford SC, Evens AM, Davison K, Punnett A, Parsons SK, Ahmed S, Casulo C, Bartlett NL, Tuscano JM, Mei MG, Hess BT, Jacobs R, Saeed H, Torka P, Hu B, Moskowitz C, Kaur S, Goyal G, Forlenza C, Doan A, Lamble A, Kumar P, Chowdhury S, Brinker B, Sharma N, Singh A, Blum KA, Perry AM, Kovach AE, Hodgson D, Constine LS, Shields LK, Prica A, Dillon H, Little RF, Shipp MA, Crump M, Kahl B, Leonard JP, Smith SM, Song JY, Kelly KM, Friedberg JW. Herrera AF, et al. Among authors: kumar p. N Engl J Med. 2024 Oct 17;391(15):1379-1389. doi: 10.1056/NEJMoa2405888. N Engl J Med. 2024. PMID: 39413375 Free PMC article. Clinical Trial.
Continuous or Fixed-Duration Maintenance Therapy in Multiple Myeloma.
Kumar S, Jacobus S, Cohen A, Weiss M, Callander N, Singh A, Parker T, Green M, Thertulien R, Parsons B, Kumar P, Kapoor P, Rosenberg A, Dib E, Almquist D, Zonder J, Faber E, Wei Z, Anderson K, Lonial S, Richardson P, Orlowski R, Wagner L, Rajkumar SV. Kumar S, et al. Among authors: kumar p. N Engl J Med. 2026 Jul 16;395(3):221-232. doi: 10.1056/NEJMoa2600157. N Engl J Med. 2026. PMID: 42456135 Free PMC article. Clinical Trial.
Fine-tuning of gene expression through the Mettl3-Mettl14-Dnmt1 axis controls ESC differentiation.
Quarto G, Li Greci A, Bizet M, Penning A, Primac I, Murisier F, Garcia-Martinez L, Borges RL, Gao Q, Cingaram PKR, Calonne E, Hassabi B, Hubert C, Herpoel A, Putmans P, Mies F, Martin J, Van der Linden L, Dube G, Kumar P, Soin R, Kumar A, Misra A, Lan J, Paque M, Gupta YK, Blomme A, Close P, Estève PO, Caine EA, Riching KM, Gueydan C, Daniels DL, Pradhan S, Shiekhattar R, David Y, Morey L, Jeschke J, Deplus R, Collignon E, Fuks F. Quarto G, et al. Among authors: kumar p. Cell. 2025 Feb 20;188(4):998-1018.e26. doi: 10.1016/j.cell.2024.12.009. Epub 2025 Jan 17. Cell. 2025. PMID: 39826545 Free PMC article.
Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826.
Rutherford SC, Li H, Herrera AF, LeBlanc M, Ahmed S, Davison K, Parsons SK, Unger JM, Perry AM, Casulo C, Bartlett NL, Tuscano JM, Hess BT, Torka P, Kumar P, Jacobs R, Song JY, Castellino SM, Kahl B, Leonard JP, Smith SM, Friedberg JW, Evens AM. Rutherford SC, et al. Among authors: kumar p. J Clin Oncol. 2025 Sep 20;43(27):2968-2973. doi: 10.1200/JCO-25-00204. Epub 2025 Jun 16. J Clin Oncol. 2025. PMID: 40523203 Free PMC article. Clinical Trial.
Improved Survival With Adjuvant Cyclooxygenase 2 Inhibition in PIK3CA-Activated Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance).
Nowak JA, Twombly T, Ma C, Shi Q, Haruki K, Fujiyoshi K, Väyrynen J, Zhao M, Knight J, Mane S, Shergill A, Kumar P, Couture F, Kuebler P, Krishnamurthi S, Tan B, Philip P, O'Reilly EM, Shields AF, Ogino S, Fuchs CS, Meyerhardt JA. Nowak JA, et al. Among authors: kumar p. J Clin Oncol. 2024 Aug 20;42(24):2853-2859. doi: 10.1200/JCO.23.01680. Epub 2024 Jun 18. J Clin Oncol. 2024. PMID: 38889377 Free PMC article. Clinical Trial.
Predictive Role of Circulating Tumor DNA in Stage III Colon Cancer Treated With Celecoxib: A Post Hoc Analysis of the CALGB (Alliance)/SWOG 80702 Phase 3 Randomized Clinical Trial.
Zhang GQ, Meyerhardt JA, Shi Q, Twombly T, Pederson L, Ma C, Väyrynen JP, Zhao M, Takashima Y, Shergill A, Kumar P, Couture F, Kuebler P, Krishnamurthi S, Tan B, O'Reilly EM, Giannakis M, Ogino S, Jurdi A, Sharma S, Aleshin A, Shields AF, Nowak JA. Zhang GQ, et al. Among authors: kumar p. JAMA Oncol. 2026 Feb 1;12(2):149-158. doi: 10.1001/jamaoncol.2025.5144. JAMA Oncol. 2026. PMID: 41343176 Free PMC article. Clinical Trial.
Defining the Middle Corona.
West MJ, Seaton DB, Wexler DB, Raymond JC, Del Zanna G, Rivera YJ, Kobelski AR, Chen B, DeForest C, Golub L, Caspi A, Gilly CR, Kooi JE, Meyer KA, Alterman BL, Alzate N, Andretta V, Auchère F, Banerjee D, Berghmans D, Chamberlin P, Chitta LP, Downs C, Giordano S, Harra L, Higginson A, Howard RA, Kumar P, Mason E, Mason JP, Morton RJ, Nykyri K, Patel R, Rachmeler L, Reardon KP, Reeves KK, Savage S, Thompson BJ, Van Kooten SJ, Viall NM, Vourlidas A, Zhukov AN. West MJ, et al. Among authors: kumar p. Sol Phys. 2023;298(6):78. doi: 10.1007/s11207-023-02170-1. Epub 2023 Jun 14. Sol Phys. 2023. PMID: 37325237 Free PMC article. Review.
1,200 results